Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project (Q30485286)

22 June 2017

Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project (English)

1 reference

22 June 2017

1 reference

Olga Basso

2

0 references

author name string

Lucy Gilbert

1

1 reference

22 June 2017

John Sampalis

3

1 reference

22 June 2017

Igor Karp

4

1 reference

22 June 2017

Claudia Martins

5

1 reference

22 June 2017

Jing Feng

6

1 reference

22 June 2017

Sabrina Piedimonte

7

1 reference

22 June 2017

Louise Quintal

8

1 reference

22 June 2017

Agnihotram V Ramanakumar

9

1 reference

22 June 2017

Janet Takefman

10

1 reference

22 June 2017

Maria S Grigorie

11

1 reference

22 June 2017

Giovanni Artho

12

1 reference

22 June 2017

Srinivasan Krishnamurthy

13

1 reference

22 June 2017

DOvE Study Group

14

1 reference

22 June 2017

17 January 2012

1 reference

Lancet Oncology Commission

22 June 2017

1 reference

22 June 2017

13

1 reference

22 June 2017

285-291

1 reference

22 June 2017

3

1 reference

22 June 2017

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

Improved survival time: what can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

1 reference

7 January 2021

"Primary peritoneal" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

A randomized study of screening for ovarian cancer: a multicenter study in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: Findings from the initial screen of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

Effect of Screening on Ovarian Cancer Mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

Development of an ovarian cancer symptom index: possibilities for earlier detection.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

Frequency of symptoms of ovarian cancer in women presenting to primary care clinics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

Symptoms associated with diagnosis of ovarian cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

Risk of ovarian cancer in women with symptoms in primary care: population based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

Identifying symptoms of ovarian cancer: a qualitative and quantitative study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

Ovarian cancer: can we make the clinical diagnosis earlier?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

Women's experiences with ovarian cancer: reflections on being diagnosed.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

Ovarian carcinoma diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

A new model of ovarian carcinogenesis may influence early detection strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

Epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

Can the preoperative Ca-125 level predict optimal cytoreduction in patients with advanced ovarian carcinoma? A single institution cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

Intercepting pelvic cancer in the distal fallopian tube: theories and realities

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

Feasibility of screening for ovarian cancer using symptoms as selection criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

Pathways to the diagnosis of ovarian cancer in the UK: a cohort study in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

Recent progress in the diagnosis and treatment of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970333-3

7 January 2021

10.1016/S1470-2045(11)70333-3

Identifiers

DOI

1 reference

22 June 2017

1 reference